Minocycline Inhibits Apoptotic Cell Death in a Murine Model of Partial Flap Loss

ABSTRACT

For breast reconstruction, the deep inferior epigastric perforator (DIEP) flap has become standard therapy. A feared complication is partial or even total flap loss. In a novel murine model of partial DIEP flap loss, the contribution of apoptotis to flap loss was investigated. The clinically available apoptosis-inhibiting compound minocycline was tested for its ability to reduce cell death. The effect of minocycline on cell proliferation was studied in cell cultures of breast carcinoma. In 12 mice, pedicled DIEP flaps were raised, which were subjected to 15 minutes of ischemia and 4 days of reperfusion. Six mice were treated with minocycline 2 hours before surgery and every 24 hours for 4 days. Apoptosis was revealed by injecting annexin A5 30 minutes before sacrifice. Annexin A5 binds to phosphatidylserines, which are expressed on the cell membrane during apoptotis. Prior to sacrifice, necrosis was measured using planimetry. Minocycline reduced cell death after 4 days from 35.9% (standard deviation = 10.6) to 13.9% (standard deviation = 8.0; p < 0.05). Apoptosis, as shown by annexin A5 binding in nontreated animals, was abundant. Minocycline did not influence tumor growth in cell cultures of human breast cancer. Minocycline treatment leads to increased DIEP flap viability in mice. This study widens the perspective in the improvement of free flap survival in patients.

Free flap - DIEP flap - apoptosis - minocycline - annexin A5 - breast reconstruction

REFERENCES

• 1 Erdmann D, Sundin B M, Moquin K J, Young H, Georgiade G S. Delay in unipedicled TRAM flap reconstruction of the breast: a review of 76 consecutive cases.  Plast Reconstr Surg. 2002;  110 762-767
• 2 Hartrampf Jr C R. The transverse abdominal island flap for breast reconstruction. A 7-year experience.  Clin Plast Surg. 1988;  15 703-716
• 3 Paige K T, Bostwick III J, Bried J T, Jones G. A comparison of morbidity from bilateral, unipedicled and unilateral, unipedicled TRAM flap breast reconstructions.  Plast Reconstr Surg. 1998;  101 1819-1827
• 4 Lineaweaver W C, Lei M P, Mustain W, Oswald T M, Cui D, Zhang F. Vascular endothelium growth factor, surgical delay, and skin flap survival.  Ann Surg. 2004;  239 866-873 discussion 873-875
• 5 Dumont E A, Reutelingsperger C P, Smits J F et al.. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart.  Nat Med. 2001;  7 1352-1355
• 6 Hofstra L, Dumont E A, Thimister P W et al.. In vivo detection of apoptosis in an intracardiac tumor.  JAMA. 2001;  285 1841-1842
• 7 Dumont E A, Hofstra L, van Heerde W L et al.. Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model.  Circulation. 2000;  102 1564-1568
• 8 Hofstra L, Liem I H, Dumont E A et al.. Visualisation of cell death in vivo in patients with acute myocardial infarction.  Lancet. 2000;  356 209-212
• 9 Yrjänheikki J, Tikka T, Keinänen R, Goldsteins G, Chan P H, Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window.  Proc Natl Acad Sci U S A. 1999;  96 13496-13500
• 10 Sutton T A, Kelly K J, Mang H E, Plotkin Z, Sandoval R M, Dagher P C. Minocycline reduces renal microvascular leakage in a rat model of ischemic renal injury.  Am J Physiol Renal Physiol. 2005;  288 F91-F97
• 11 Klein M B, Chan P H, Chang J. Protective effects of superoxide dismutase against ischemia-reperfusion injury: development and application of a transgenic animal model.  Plast Reconstr Surg. 2003;  111 251-255 discussion 256-257
• 12 Hallock G G, Rice D C. Comparison of TRAM and DIEP flap physiology in a rat model.  Plast Reconstr Surg. 2004;  114 1179-1184
• 13 Gieseler A, Schultze A T, Kupsch K et al.. Inhibitory modulation of the mitochondrial permeability transition by minocycline.  Biochem Pharmacol. 2009;  77 888-896
• 14 Orsucci D, Calsolaro V, Mancuso M, Siciliano G. Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease.  CNS Neurol Disord Drug Targets. 2009;  8 222-231
• 15 Scarabelli T M, Stephanou A, Pasini E et al.. Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO.  J Am Coll Cardiol. 2004;  43 865-874
• 16 Sapadin A N, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications.  J Am Acad Dermatol. 2006;  54 258-265